U.S. FDA Issues Official Action Indicated Warning to Aurobindo Pharma’s U.S. Formulation Unit
The U.S. Food and Drug Administration has classified Aurobindo Pharma’s formulation manufacturing facility in the United States as Official Action Indicated (OAI), signaling serious compliance…